Get Low Cost Parkinsons Disease Treatment In India
We offer free assistance to international patients to find best medical treatment in India. We offer low-cost, world-class medical treatment in India, coordinated by a team of experienced service industry professionals
Please post a query to know about low cost treatment options at top India hospitals
Dont Miss: Does Vitamin B12 Help Parkinsons
What Is The Best Treatment For Parkinsons Disease
According to the experts at the Mayo Clinic, there is no cure for Parkinsons disease. There are many organizations such as the Michael J. Fox foundation started to find a cure for Michael J. Fox Parkinsons funding research for a Parkinsons cure. Currently, doctors specializing in Parkinsons disease, such as renowned expert Dr. Fazzini, prescribe the best medicine for Parkinsons disease symptom control as the best treatment for Parkinsons disease.
Dr. Russell Blaylock, the renowned Neuro-Surgeon, states that the medication for Parkinsons mainstay Parkinsons treatment that most patients will receive will almost guarantee that they will get worse in 2-5 years, and it even appears that Parkinsons medication speeds the deterioration!
How Long Does A Stem Cell Therapy Take
The initial analyses and counseling can be done without you having to travel to Offenbach . This period can be 2 weeks up to months depending on the availability of patients slots. If you live further away, we will conduct the initial discussions by telephone or video conference. For the actual treatment, you will travel to Offenbach.
Don’t Miss: Parkinson’s Short Term Memory Loss
Background On Parkinsons And Pd
Parkinsons is a neurodegenerative disease that manifests through movement disorders and other health issues. Current treatments only have a symptomatic effect. PD-MitoQUANT is intended to break ground for better therapies. The project will run for three years, involving 14 partners from nine countries, both form academia and industry. PD-MitoQUANT is a research project of the Innovative Medicines Initiative, a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations . As such PD-MitoQUANT is receiving 4.5 million euro in funding from the EUs Horizon 2020 programme and 2.46 million euro in-kind from EFPIA members and Parkinsons UK, a British patient advocacy organization.
How Has The Coronavirus Crisis Affected Access To Treatment For People With Parkinsons
Helmich: This is a topic that many patients are worried about: access to health care. Many Parkinson patients are treated by a whole team of professionals, including a neurologist, a Parkinson nurse, a physical therapist, and sometimes a psychiatrist, speech therapist, or occupational therapist. Access to these health care providers has been restricted by the isolation and social distancing measures. Not all people have good access to internet, and not all treatments can be given through video conferencing. So, I believe that the care for Parkinson patients has certainly suffered from the coronavirus pandemic.
Ferreira: The coronavirus pandemic severely affected the follow-up of people with Parkinsons disease. The regular consultations were cancelled, making it more difficult or impossible the access to physicians and other health professionals. Pharmacological prescriptions were more difficult to obtain. Sessions of physiotherapy, speech therapy and other therapeutic interventions were cancelled, and physical activity and exercise was highly reduced for many patients. Many deep brain surgeries were deferred, and patients included in research studies and clinical trials saw their consultations being moved to phone contacts or videocalls.
Read Also: What Triggers Parkinson’s Disease
Radiosurgery With Gamma Radiation
Treatment with radiosurgery is available in only few centers worldwide, and no RCT has been published with this method for the treatment of advanced PD or tremor of PD. Open-label and prospective collections of case series are available. One study used blinded evaluation outcomes . The occurrence of potentially dangerous adverse effects such as continuing evolving lesions long after the application of the radiation were reported . In contrast to all other interventions, there is no possibility to control the effect of the lesion before it is complete because the destruction of the tissue and subsequent clinical effects due to radiation take days to weeks. Therefore, a reversible test is not possible. We are aware that it is an incisionless procedure that may be needed for rare clinical situations, but other interventions are available and should be preferred.
These facts have led this GL group not to consider it as a treatment option. It is not a recommended option for the treatment of advanced PD, neither as thalamotomy, pallidotomy, nor as a lesioning technique for the STN.
Clinical Consensus Statement 3: RCTs for unilateral gamma radiation radiosurgery of any of the three target nuclei are not available for people with PD. Due to potential high risks for AEs, this GL task force does not recommend this treatment .
European Medicines Agency Finalises Update To Parkinson’s Disease Guideline
The European Medicines Agency has published an update to its guidance for pharmaceutical companies developing medicines for Parkinson’s disease.
The update to the guideline on clinical investigation of medicinal products in the treatment of Parkinson’s disease , published today, covers how companies should design and carry out studies of medicines that aim to improve the disease’s symptoms in patients and to modify the progress of the disease itself.
The update brings the guideline in line with recent scientific and medical developments in Parkinson’s disease. It includes new information on the definition of newly diagnosed patients and updates to the criteria for including patients in clinical trials and statistical analyses.
The guideline was last published in 2008.
Parkinson’s disease is a common neurological disease that tends to affect older people. It causes slowed movement, rigid muscles and problems with posture and usually gets worse over a number of years.
A number of medicines to treat the disease’s symptoms are authorised, but there are currently no authorised medicines that have been shown to stop its progression.
The guideline is effective immediately. It is accompanied by a question-and-answer document giving more information on inclusion criteria explained in the updated guideline.
Read Also: What Does It Feel Like To Have Parkinson’s
What Do We Know About The Relationship Between Coronavirus And Parkinsons
Joaquim Ferreira, neurologist, Portugal:There is still scarce information regarding many clinical aspects of this infection and its potential short- and long-term complications. We know that the majority of people with Parkinsons are elderly, and age is a risk factor for the more severe forms of Covid-19. On the other hand, we recognise that patients might be affected indirectly by the lockdown physical restrictions, the psychological impacts and the compromised healthcare.
Miriam Parry, senior Parkinsons Disease nurse specialist, UK: We do know that people with Parkinsons are more prone to pneumonia and infections. Parkinsons can cause respiratory issues for some people if you have lived with Parkinsons for a long time, you are more likely to have breathing and respiratory difficulties. This is why people with Parkinsons are described as being at greater risk of severe illness if they get coronavirus. As such, their caregivers need to take precautions.
What Medications Are Used To Treat Parkinson’s Symptoms
Since many of the motor symptoms of Parkinsons are the result of a lack of dopamine in the brain, most drugs used to treat Parkinsons are aimed at temporarily replenishing or imitating dopamine. The following list is a guide to medications approved by Health Canada to treat symptoms of Parkinsons1. Speak to your doctor for detailed information regarding effectiveness and side effects of a particular drug.
- Converted into dopamine in the brain and stored in nerve cells to replace depleted dopamine
- Combined with another drug, carbidopa or benzerazide, allows more levodopa to get to the brain and reduces side effects
- Helps improve muscle rigidity and movement
- Side effects include dyskinesias
- Over years of use, may be associated with wearing off
- Mimics or imitates action of dopamine
- Can be used as initial treatment or with levodopa in advanced stages
- Side effects include sleepiness, hallucinations, leg swelling and obsessions with food, sex and activities such as shopping, gambling and Internet use Amantadine
- Enhances dopamine release and blocks glutamate, a brain transmitter
- Used to treat early symptoms
- Can reduce dyskinesias and improve wearing off
Recommended Reading: Does Parkinson Cause Muscle Spasms
What Is The Cost Of Stem Cell Therapy For Parkinsons Disease In India
Stem Cell Therapy is a very convoluted treatment modality. As the cost is not regulated in most of the parts of the world for stem cell therapy, people from across the globe prefer India as it has become the hub of medical tourism for highly affordable stem cell therapy. The treatment cost here is significantly less of what it would cost in the western countries along with the waiting period and very expensive logistic cost.
The cost of Stem Cell Therapy for Parkinsons disease in other European countries cost approx. $30,000 $35,000. However, in India, it will cost you almost 70% to 80% less than that.
The cost of stem cell therapy depends upon various medical factors like the type of stem cell treatment, type of cells, the number of stem cells required, type of stem cells, pre-treatment investigations, etc.
Fair pricing of Stem Cell Treatment in India is also a factor which is giving a new ray of hope to the patients who are in need of Stem Cell Therapy. Stem Cell Therapy cost in India is significantly economical but the medical services provided by the hospitals are top notch with International Medical standards and latest technologies.
What Actions Should People With Parkinsons Take At The Moment
Ferreira: The most important recommendation for people with Parkinsons and their close friends and family is to follow the general public health recommendations that apply to the elderly population. At the current stage of the pandemic, when governments are lowering the confinement measures, the most important message is to alert everybody that this pandemic is not over and the general measures that are being recommended for the general population should be followed strictly in the next months.
Parry: When you leave the house, for any reason, you should avoid busy spaces and keep a distance of around two meters from people you do not live with, while wearing a face mask. You should also continue to follow good hygiene practices, including handwashing, not sharing crockery and cutlery, wiping down surfaces, and not entering other peoples homes. You can ask your local pharmacist to deliver medication to your home address or ask family members or friends to help.
Edwards: I would really advocate for people, if they can, to exercise. It has proven benefits not just for physical health in Parkinsons but for promoting good mental health. Ive been really impressed with the exercise classes available online to people with Parkinsons whilst the group classes have been postponed.
Senior Parkinsons Disease nurse specialist Miriam Parry
Don’t Miss: Most Effective Treatment For Parkinson’s
What Causes Parkinsons Disease
The underlying cause for the death of nerve cells in the brain are unknown. Several factors are known to play a role:
- Genes: Specific gene mutations were shown to increase the risk for PD
- Environment: Exposure to certain toxins may increase PD risk.
- Age: Usually the age of 60 is the age where PD is most prone to happen
- Sex: Men are more likely to develop PDOccurring changes in PD
How Much Does Stem Cell Treatment Cost
Our treatments are always tailored to your specific situation, disease, stage and other factors. The therapies differ in the product used , the frequency of treatment as well as the further examinations and your sedation and anesthesia wishes. A treatment for PD will cost above ten thousand euros. You will receive a cost estimate for all treatments in advance so that you can accurately estimate what a treatment would cost in your individual case.
Recommended Reading: How To Control Parkinson’s Disease
Lesioning Of The Stn With Radiofrequency Thermocoagulation
There is only one larger case series on radiofrequency lesioning of the STN, which concluded acceptable feasibility with an open follow-up . It reported some efficacy but also some cases with ongoing surgically induced dyskinesia. The procedure has never been tested in an RCT . It cannot be recommended by this GL group as a treatment for advanced PD.
Clinical Consensus Statement 2: RCTs for unilateral radiofrequency thermocoagulation of the STN for people with PD are not available. Due to potential high risks for AEs, this GL task force does not recommend this treatment .
Movement Disorder Treatment A Convenient Flight From Europe
The Mayo Clinic Defines Movement Disorders as:
The term movement disorders refers to a group of nervous system conditions that cause abnormal increased movements, which may be voluntary or involuntary. Movement disorders can also cause reduced or slow movements.
Common types of movement disorders include: Citation
Ataxia. This movement disorder affects the part of the brain that controls coordinated movement . Ataxia may cause uncoordinated or clumsy balance, speech or limb movements, and other symptoms. Ataxia signs and symptoms are often confused with signs and symptoms of Parkinsons disease
Cervical dystonia. This condition causes long-lasting contractions or intermittent contractions of the neck muscles, causing the neck to turn in different ways.
Chorea. Chorea is characterized by repetitive, brief, irregular, somewhat rapid, involuntary movements that typically involve the face, mouth, trunk and limbs.
Huntingtons disease. This is an inherited progressive, neurodegenerative disorder that causes uncontrolled movements , impaired cognitive abilities and psychiatric conditions. Some signs of huntingtons mimic signs of Parkinsons.
Multiple system atrophy. This uncommon, progressive neurological disorder affects many brain systems. Multiple system atrophy causes a movement disorder, such as ataxia or Parkinsonism. It can also cause low blood pressure and impaired bladder function.
You May Like: Flexibility Exercises For Parkinson’s Disease
Drug And Medication Therapies
The purpose of treating Parkinsons is to reduce the effect of symptoms on your daily life. Without treatment, you will eventually find that the symptoms make it hard to perform daily activities. Symptoms, such as shaking and stiffness, may cause discomfort the risk of injury from falls may increase, and swallowing may become more difficult. People are encouraged to maintain open and ongoing discussions with their Parkinsons healthcare team when exploring treatment options.
Medication will help you function, but may cause side effects. It is important to find the right balance between the medications benefits and side effects. Everyone with Parkinsons is unique and will experience different symptoms, which means the treatment you receive will be geared to your specific needs. Drugs for Parkinsons work on the brains complex chemistry and may need to be taken several times a day. Use them as prescribed and do not alter your doses without consulting your doctor. Current treatment neither cures Parkinsons nor stops it from advancing.
Thalamotomy With Radiofrequency Thermocoagulation
This procedure has been used to treat thousands of people with tremor-dominant PD and has mostly been applied unilaterally. Bilateral application had the disadvantage of frequent dysarthria in up to 40% of the patients and it has, therefore, only been applied since the second half of the last century. The higher number of AEs with radiofrequency compared with thalamic DBS for unilateral and particularly for bilateral procedures was shown in a controlled trial and was the main reason that this treatment has mostly been abandoned. This GL group identified no RCTs that fulfill the inclusion criteria, and no recommendations according to the GRADE-methodology are possible. Therefore, the procedure cannot be recommended. However, the GL committee is aware that unilateral procedures are still used for selected indications when no other treatment options are available or in countries that have no other interventions available.
Clinical Consensus Statement 1: RCTs for unilateral radiofrequency thermocoagulation of the thalamus for parkinsonian tremor or advanced PD are not available, and formal recommendations are not possible. As DBS has a better safety profile, this GL task force does not recommend this treatment if safer treatments are available .
Also Check: Exercises For Parkinson’s Gait
What Is Dbs Surgery
Deep brain stimulation is a surgery to implant a device that sends electrical signals to brain areas responsible for body movement. Electrodes are placed deep in the brain and are connected to a stimulator device. DBS can help reduce the symptoms of tremor, slowness, stiffness, and walking problems caused by Parkinsons disease, dystonia, or essential tremor. Successful DBS allows people to potentially reduce their medications and improve their quality of life. In Parkinsons, parts of the basal ganglia are either under- or over-stimulated. Normal movement is replaced by tremor, rigidity and stiffness. DBS of specific ganglia alters the abnormal electrical circuits and helps stabilize the feedback loops, thus reducing symptoms.
Electrodes can be placed in the following brain areas:
- Subthalamic nucleus Effective for tremor, slowness, rigidity, dystonia and dyskinesia. Most commonly used on the way to treat Parkinsons disease.
- Thalamus Effective for tremor. It is often used to treat essential tremor.
- Globus pallidus Effective for tremor, slowness, rigidity, dystonia and dyskinesia. It is used to treat dystonia and Parkinsons disease.
Do You Think The Coronavirus Crisis Will Have A Long
Ferreira: The limitations induced by the Covid-19 pandemic are here to stay and we need to be prepared to adapt for the next months.
Parry: The Covid-19 pandemic could potentially have a long-term impact on the physical and mental health of people with Parkinsons, and many studies are currently taking place looking at the effect of this pandemic.
Edwards: I think lots of clinicians were hoping that we could eventually use technology in how we review our patients, and this crisis has pushed that to the forefront. I like being able to offer our patients a wider range of ways that they can access information and advice from virtual clinics to wearing digital technology but also being able to offer more traditional face-to-face home visits if needed.
Mental health nurse and Parkinsons specialist nurse Emma Edwards
Need to know
Emma Edwards: Im a mental health nurse in the UK however for the last 10 years Ive worked as a Parkinsons specialist nurse in the community. I had worked in a large rural area for many years, but more recently have moved to a post in a city. Due to the lockdown on clinical work environments, my dining room is currently my office!
For more information about Parkinsons and coronavirus please visit the EPDA website.
Don’t Miss: Michael J Fox Parkinson’s Book